封面
市场调查报告书
商品编码
1671839

速溶片市场按类型、适应症、剂型、年龄层、通路和地区划分

Fast Melt Tablets Market, By Type, By Indication, By Dosage Form, By Age Group, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球速溶片市场规模估计为 62 亿美元,预计到 2032 年将达到 114.1 亿美元,2025 年至 2032 年的复合年增长率为 9.1%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 62亿美元
效能资料 从 2020 年到 2024 年 预测期 2025 至 2032 年
预测期:2025-2032年复合年增长率: 9.10% 2032 年价值预测 114.1亿美元
图。
速溶片市场-IMG1

速溶片是口溶锭在口中瞬间崩坏、溶解,无需咀嚼或喝水。它们经过优化设计,可以在口中快速崩坏或溶解,使其更容易吞嚥。速溶片一般适用于吞嚥传统锭剂或胶囊有困难的患者,如儿童、老年人、吞嚥障碍患者。速溶片旨在在口腔内溶解并释放药物,因此吞嚥时无需用水。此技术方便了吞嚥功能受损患者的给药,提高了患者的遵从性。

市场动态:

全球速溶片市场的发展受到老年人口不断增长的推动,老年人难以吞嚥传统的锭剂和胶囊。与传统锭剂相比,主要的阻碍因素是速溶片剂的製造成本较高。然而,预计在预测期内,提高患者依从性和易于管理等优势(尤其是对儿科和老年患者而言)将为市场成长提供丰厚的机会。

本研究的主要特点

本报告对全球速溶片市场进行了详细分析,并给出了预测期(2025-2032)的市场规模和年复合成长率(CAGR%),假设 2024 年为基准年。

它还揭示了各个领域的潜在商机,并解释了该市场有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球速溶片市场的主要企业是根据公司亮点、产品系列、关键亮点、性能和策略等参数进行的分析。

研究涉及的主要企业包括辉瑞公司、葛兰素史克公司、强生公司、默克公司、诺华公司、赛诺菲公司、梯瓦製药工业有限公司、迈兰公司、安进公司、艾尔建公司、阿拉宾度製药有限公司、Hikma Pharmaceuticals 公司、太阳製药工业有限公司、Strides Pharma Science Limited 和 Zydus Cadila。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

本全球速溶片市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员将透过用于分析全球速溶片市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 司机
  • 限制因素
  • 机会
  • 影响分析
  • 主要进展
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • PORTER 分析
  • 併购情景
  • 产业趋势

4. 2020 年至 2032 年全球速溶片市场(按类型划分)(十亿美元)

  • 抗精神病药物
  • 抗惊厥药
  • 兴奋剂
  • 抗焦虑药物
  • 抗帕金森氏症药物
  • 抗高血压药物
  • NSAIDs
  • 抗过敏药物
  • 质子帮浦抑制剂
  • 其他的

5. 全球速溶片市场,按适应症,2020-2032 年(十亿美元)

  • 疼痛管理
  • 过敏和呼吸系统疾病
  • 神经系统疾病
  • 胃肠道疾病
  • 心血管疾病
  • 其他的

6. 2020 年至 2032 年全球速溶片市场(以剂型划分)(十亿美元)

  • 口服
  • 舌下
  • 口服
  • 咀嚼片

7. 2020 年至 2032 年全球速溶片市场(依年龄层划分)(十亿美元)

  • 成人
  • 孩子们
  • 老年人

8. 全球速溶片市场,依通路,2020-2032 年(十亿美元)

  • 医院药房
  • 零售药局
  • 网路药局

9. 2020 年至 2032 年全球速溶片市场,按地区划分,价值(十亿美元)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲
    • 北非
    • 中部非洲

第十章 竞争格局

  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.
  • Mylan NV
  • Amgen Inc.
  • Allergan plc
  • Aurobindo Pharma Ltd.
  • Hikma Pharmaceuticals plc
  • Sun Pharmaceutical Industries Ltd.
  • Strides Pharma Science Limited
  • Zydus Cadila

第 11 章 分析师建议

  • 命运之轮
  • 分析师观点
  • 一致的机会图

第 12 章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI7726

The Global Fast Melt Tablets Market is estimated to be valued at USD 6.20 Bn in 2025 and is expected to reach USD 11.41 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.20 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.10% 2032 Value Projection: USD 11.41 Bn
Figure. Fast Melt Tablets Market Share (%), By Region, 2025
Fast Melt Tablets Market - IMG1

Fast melt tablets refer to orally disintegrating tablets that disintegrate or dissolve instantaneously in the oral cavity without chewing or the need of water. They are optimally designed to rapidly disintegrate or dissolve in the mouth, thereby facilitating swallowing. Fast melt tablets generally target patients who experience difficulties in swallowing conventional tablets and capsules such as pediatric, geriatric patients, and those with dysphagia. Rapidly dissolving tablets are designed to dissolve and release the drugs in buccal cavity eliminating the need of water for swallowing. This technology offers ease of administration to patients with impaired ability to swallow and enhances patient compliance.

Market Dynamics:

The global fast melt tablets market is driven by growing geriatric population who experience difficulty in swallowing conventional tablets and capsules. The key restraining factor includes high cost of manufacturing fast melt tablets as compared to conventional tablets. However, advantages such as enhanced patient compliance and convenience of administration especially for pediatric and geriatric patients is expected to provide lucrative opportunities for market growth over the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global fast melt tablets market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global fast melt tablets market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Amgen Inc., Allergan plc, Aurobindo Pharma Ltd., Hikma Pharmaceuticals plc, Sun Pharmaceutical Industries Ltd., Strides Pharma Science Limited, and Zydus Cadila

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global fast melt tablets market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fast melt tablets market

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Anti Psychotics
    • Anti Epileptics
    • CNS Stimulants
    • Anxiolytics
    • Anti Parkinsonian Drugs
    • Anti Hypertensive
    • NSAIDs
    • Anti Allergy Drugs
    • Proton Pump Inhibitors
    • Others
  • Indication Insights (Revenue, USD Bn, 2020 - 2032)
    • Pain Management
    • Allergy and Respiratory Disorders
    • Neurological Disorders
    • Gastrointestinal Disorders
    • Cardiovascular Disorders
    • Others
  • Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
    • Oral
    • Sublingual
    • Buccal
    • Chewable
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Adult
    • Pediatrics
    • Geriatrics
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Novartis AG
    • Sanofi S.A.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Amgen Inc.
    • Allergan plc
    • Aurobindo Pharma Ltd.
    • Hikma Pharmaceuticals plc
    • Sun Pharmaceutical Industries Ltd.
    • Strides Pharma Science Limited
    • Zydus Cadila

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Fast Melt Tablets Market, By Type
    • Global Fast Melt Tablets Market, By Indication
    • Global Fast Melt Tablets Market, By Dosage Form
    • Global Fast Melt Tablets Market, By Age Group
    • Global Fast Melt Tablets Market, By Distribution Channel
    • Global Fast Melt Tablets Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Fast Melt Tablets Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Anti Psychotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Epileptics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • CNS Stimulants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anxiolytics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Parkinsonian Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Hypertensive
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • NSAIDs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anti Allergy Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Proton Pump Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Fast Melt Tablets Market, By Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pain Management
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Allergy and Respiratory Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gastrointestinal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiovascular Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Fast Melt Tablets Market, By Dosage Form, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sublingual
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Buccal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chewable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Fast Melt Tablets Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Fast Melt Tablets Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Fast Melt Tablets Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Amgen Inc.
  • Allergan plc
  • Aurobindo Pharma Ltd.
  • Hikma Pharmaceuticals plc
  • Sun Pharmaceutical Industries Ltd.
  • Strides Pharma Science Limited
  • Zydus Cadila

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us